Table 1 Characteristics of RENVOR study population
RENVOR study population (n = 233) 1 | Subset with regular previous health examinations (n = 77) | ||||
|---|---|---|---|---|---|
Women | Men | Women | Men | ||
N (%) | 115 (49.4%) | 118 (50.6%) | 35 (45.5%) | 42 (54.5%) | |
Age (years), median (Q1, Q2) | 60.6 (54.5, 66.9) | 60.3 (52.2, 64.9) | 60.7 (51.5, 67.0) | 62.8 (57.9, 66.4) | |
Smoking status | Ever smoker | 38 (33.0%) | 68 (57.6%) | 13 (37.1%) | 27 (64.3%) |
Disease status | Diabetes Mellitus | 38 (33.0%) | 47 (39.8%) | 7 (20.0%) | 13 (31.0%) |
Hypertension | 96 (83.5%) | 91 (77.1%) | 27 (77.1%) | 29 (69.1%) | |
Cardiovascular disease | 12 (10.4%) | 27 (22.9%) | 1 (2.9%) | 11 (26.2%) | |
Time since first diagnosis of underlying disease2 (years), (N = 190), median (Q1, Q3) | 8.0 (2.0, 14.0) | 6.0 (2.0, 12.0) | 7.5 (2.5, 15.0) | 6.0 (3.0, 13.0) | |
Laboratory parameters [median (Q1, Q3)] | |||||
WHR | 0.87 (0.84, 0.92) | 0.97 (0.92, 1.02) | 0.86 (0.83, 0.92) | 0.96 (0.90, 1.02) | |
BMI (kg/m2) | 27.5 (24.5, 31.6) | 29.4 (26.1, 32.9) | 25.5 (23.5, 28.6) | 27.0 (25.4, 31.8) | |
Total cholesterol (mmol/l) | 5.24 (4.73, 6.09) | 5.00 (4.19, 5.75) | 5.32 (4.73, 6.36) | 5.02 (4.22, 5.74) | |
LDL cholesterol (mmol/l) | 2.46 (1.97, 2.97) | 2.30 (1.78, 2.90) | 2.35 (1.91, 3.00) | 2.34 (1.86, 2.87) | |
HDL cholesterol (mmol/l) | 1.32 (1.16, 1.58) | 1.16 (0.96, 1.37) | 1.45 (1.19, 1.63) | 1.20 (0.98, 1.42) | |
Triglycerides (mmol/l) | 1.48 (1.00, 1.90) | 1.55 (1.12, 2.30) | 1.42 (0.95, 2.04) | 1.54 (1.10, 2.10) | |
Gamma-GT (units/l) | 19.0 (13.0, 32.5) | 36.0 (24.0, 57.0) | 19.0 (13.0, 63.0) | 32.0 (24.0, 62.0) | |
CRP (mg/dl) | 0.3 (0.1, 0.6) | 0.2 (0.1, 0.3) | 0.2 (0.1, 0.6) | 0.1 (0.1, 0.3) | |
eGFR (ml/min/1.73 m2) | 95 (85, 102) | 95 (87, 102) | 95 (85, 100) | 94 (88, 101) | |
<90 ml/min/1.73 m2 | N (%) | 42 (36.5%) | 35 (29.7%) | 12 (34.3%) | 11 (26.2%) |
<60 ml/min/1.73 m2 | N (%) | 9 (7.8%) | 3 (2.5%) | 2 (5.7%) | 1 (2.4%) |
Albumin/creatinine ratio (mg/g) | 7.91 (4.64, 16.0) | 6.29 (3.53, 19.2) | 6.92 (4.64, 13.3) | 7.10 (3.52, 16.0) | |
>30 mg/g | N (%) | 17 (14.9%) | 23 (19.5%) | 2 (5.9%) | 6 (14.3%) |
GFR < 60 ml/min/1.73 m2 or ACR > 30 mg/g | N (%) | 24 (21.1%) | 24 (20.3%) | 3 (8.8%) | 7 (16.7%) |